BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 2552843)

  • 1. ACTH-(4-10) through gamma-MSH: evidence for a new class of central autonomic nervous system-regulating peptides.
    Gruber KA; Callahan MF
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R681-94. PubMed ID: 2552843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocortins and cardiovascular regulation.
    Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
    Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity analysis for the effects of gamma-MSH/ACTH-like peptides on cerebral hemodynamics in rats.
    Van Bergen P; Van Der Vaart JG; Kasbergen CM; Versteeg DH; De Wildt DJ
    Eur J Pharmacol; 1996 Dec; 318(2-3):357-68. PubMed ID: 9016926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hemodynamic effects of gamma 2-melanocyte-stimulating hormone and related melanotropins depend on the arousal potential of the rat.
    De Wildt DJ; Krugers H; Kasbergen CM; De Lang H; Versteeg DH
    Eur J Pharmacol; 1993 Mar; 233(1):157-64. PubMed ID: 8386086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of gamma-MSH/ACTH-like peptides: structure-activity relationship.
    Van Bergen P; Janssen PM; Hoogerhout P; De Wildt DJ; Versteeg DH
    Eur J Pharmacol; 1995 Dec; 294(2-3):795-803. PubMed ID: 8750747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides derived from pro-opiocortin.
    Gruber KA; Klein MC; Lymangrover JR
    Prog Clin Biol Res; 1985; 192():213-20. PubMed ID: 3001754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different cardiovascular profiles of three melanocortins in conscious rats; evidence for antagonism between gamma 2-MSH and ACTH-(1-24).
    Van Bergen P; Kleijne JA; De Wildt DJ; Versteeg DH
    Br J Pharmacol; 1997 Apr; 120(8):1561-7. PubMed ID: 9113379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions.
    Dunbar JC; Lu H
    Peptides; 2000 Feb; 21(2):211-7. PubMed ID: 10764947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central vasopressin system mediation of acute pressor effect of gamma-MSH.
    Gruber KA; Eskridge SL
    Am J Physiol; 1986 Jul; 251(1 Pt 1):E134-7. PubMed ID: 3014888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the melanocortin 3 receptor in mediating the effects of gamma-MSH peptides on the adrenal.
    Harmer SC; Bicknell AB
    Endocr Res; 2004 Nov; 30(4):629-35. PubMed ID: 15666803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic nervous system mediation of acute cardiovascular actions of gamma 2-melanocyte-stimulating hormone.
    Callahan MF; Kirby RF; Wolff DW; Strandhoy JW; Lymangrover JR; Johnson AK; Gruber KA
    Hypertension; 1985; 7(3 Pt 2):I145-50. PubMed ID: 2860063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones.
    Li SJ; Varga K; Archer P; Hruby VJ; Sharma SD; Kesterson RA; Cone RD; Kunos G
    J Neurosci; 1996 Aug; 16(16):5182-8. PubMed ID: 8756446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic terminal mediation of the acute cardiovascular response of gamma 2-MSH.
    Callahan MF; Kirby RF; Johnson AK; Gruber KA
    J Auton Nerv Syst; 1988 Sep; 24(1-2):179-82. PubMed ID: 2850308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia.
    Delgado R; Carlin A; Airaghi L; Demitri MT; Meda L; Galimberti D; Baron P; Lipton JM; Catania A
    J Leukoc Biol; 1998 Jun; 63(6):740-5. PubMed ID: 9620667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of melanocortin peptides on neural melanocortin receptors.
    Adan RA; Cone RD; Burbach JP; Gispen WH
    Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on possible modulating and direct effects of gamma2-MSH and ACTH-(1-24) on the cardiovascular system of the rat.
    Van Bergen P; Vleeming W; Van Heijst BG; Versteeg DH; De Wildt DJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):220-9. PubMed ID: 9750008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressor and cardioaccelerator effects of gamma MSH and related peptides.
    Klein MC; Hutchins PM; Lymangrover JR; Gruber KA
    Life Sci; 1985 Feb; 36(8):769-75. PubMed ID: 2983170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides.
    Moustafa M; Szabo M; Ghanem GE; Morandini R; Kemp EH; MacNeil S; Haycock JW
    J Invest Dermatol; 2002 Dec; 119(6):1244-53. PubMed ID: 12485424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and renal effects of gamma-MSH in spontaneously hypertensive and normotensive Wistar Kyoto rats.
    Sun XY; Feng QP; Gong QL; Edvinsson L; Hedner T
    Am J Physiol; 1992 Jan; 262(1 Pt 2):R77-84. PubMed ID: 1733342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-amidated peptides derived from pro-opiomelanocortin in normal human pituitary.
    Fenger M; Johnsen AH
    Biochem J; 1988 Mar; 250(3):781-8. PubMed ID: 2839146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.